Valuation (52%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.68 | N/A |
PEG Ratio (TTM) | 0.05 | N/A |
P/S Ratio (TTM) | 0.71 | N/A |
P/B Ratio (TTM) | 0.50 | N/A |
P/FCF Ratio (TTM) | 4.37 | N/A |
Price to 5YR AVG Earnings Ratio | -2.18 | N/A |
Price to 5YR AVG FCF Ratio | -4.74 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -44.65% | N/A |
ROE (TTM) | -53.85% | N/A |
Net Profit Margin (TTM) | -105.49% | N/A |
ROIC 5YR AVG | -7.05% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -413.09% | -53.29% | -93.16% |
Revenue | -9.99% | -46.60% | -19.24% |
Net Income | -420.46% | -54.63% | -95.10% |
Cash Flow | 196.85% | -129.37% | -20.32% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.25 | N/A |
Quick Ratio (TTM) | 2.13 | N/A |
D/E Ratio (TTM) | 0.18 | N/A |
Interest Coverage (TTM) | -4.82 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -1.81 | N/A |
Shares Outstanding Growth 5YR AVG | 1.32% | N/A |